Dr.Agarwals Eye Hospital Ltd.

BSE: DRAGARWQ526783ISIN INE934C01018

Healthcare
Hospital
BSE Healthcare

Share price

₹5,413.80+133.80 (+2.53%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹6,392.00
52W low: ₹4,412.05
Off 52W high: -15.30%
1M return: +4.47%
3M return: +4.16%
6M return: +5.95%
1Y return: +2.39%
20D avg volume: 101
50 DMA: ₹5,226.43
200 DMA: ₹5,009.30

Key ratios Standalone

Market cap: ₹2,616 Cr
Current price: ₹5,413.80
52W high / low: ₹6,392.00 / ₹4,412.05
Face value: ₹10.00
P/E: 34.33
P/B: 14.22
EPS (TTM): ₹157.71
Book value / share: ₹380.72
ROE: 41.41%
ROCE: 16.10%
Operating margin: 31.63%
Net margin: 16.35%
Debt / equity: 0.24
Net debt: ₹75.18 Cr
Interest cover: 8.88
Dividend yield: 0.13%
Dividend / share (TTM): ₹7.00
Payout: 4.44%
Cash conversion cycle: 4.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	142.97	120.01	116.22	117.72	116.92	99.83	95.11	102.19	100.02	80.72	75.67	83.27
	1.96	1.57	2.77	0.68	0.80	0.10	2.31	2.28	0.40	2.46	0.95	2.29
	144.93	121.58	118.99	118.40	117.72	99.93	97.42	104.47	100.42	83.18	76.62	85.56
	113.97	100.33	95.54	92.68	94.53	81.33	83.36	85.34	81.51	65.84	63.90	68.91
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	14.66	12.03	11.98	11.85	11.87	9.03	10.89	9.07	11.56	8.85	8.68	9.93
	27.48	23.96	24.10	21.44	22.18	19.95	20.90	19.90	17.57	15.41	15.51	16.43
	2.77	1.96	2.03	3.73	4.16	2.89	3.85	3.67	3.03	2.03	1.83	1.69
	11.49	12.09	11.66	11.31	10.58	10.20	10.02	9.36	9.87	7.53	6.89	6.34
	58.63	51.19	46.03	44.28	45.36	37.65	14.86	14.98	14.76	11.85	10.12	11.74
	30.96	21.25	23.45	25.72	23.19	18.60	14.06	19.13	18.91	17.34	12.72	16.65
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	30.96	21.25	23.45	25.72	23.19	18.60	14.06	19.13	18.91	17.34	12.72	16.65
	7.58	5.01	6.17	6.40	5.93	2.61	3.66	4.98	4.80	4.55	3.28	4.06
	23.38	16.24	17.28	19.32	17.26	15.99	10.40	14.15	14.11	12.79	9.44	12.59
	48.38	33.60	35.76	41.04	36.72	34.02	22.13	30.11	30.02	27.21	20.09	26.79
Key metrics
	45.22	35.30	37.14	40.76	37.93	31.69	27.93	32.16	31.81	26.90	21.44	24.68
	31.60%	29.40%	32.00%	34.60%	32.40%	31.70%	29.40%	31.50%	31.80%	33.30%	28.30%	29.60%
	16.40%	13.50%	14.90%	16.40%	14.80%	16.00%	10.90%	13.80%	14.10%	15.80%	12.50%	15.10%
	—	3.50%	—	4.70%	—	4.10%	—	—	—	—	—	—
	22.30%	20.20%	22.20%	15.20%	16.90%	23.70%	25.70%	22.70%	—	—	—	—
	35.50%	1.60%	66.20%	36.50%	22.30%	25.00%	10.20%	12.40%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	496.92	470.87	397.15	319.30	267.89	201.22
	6.98	5.82	5.09	4.97	1.76	1.26
	503.90	476.69	402.24	324.27	269.65	202.47
	402.52	383.08	331.54	262.02	220.25	170.16
	0.00	0.00	0.00	—	—	—
	50.52	47.73	43.11	35.95	30.68	23.67
	96.98	91.68	78.32	63.78	53.26	38.51
	10.49	11.88	13.44	7.17	6.87	6.23
	46.55	45.64	39.45	26.61	20.18	20.39
	200.13	186.86	158.38	45.54	40.43	26.89
	101.38	93.61	70.70	62.25	49.40	32.31
	0.00	0.00	0.00	—	—	—
	101.38	93.61	70.70	62.25	49.40	32.31
	25.16	23.51	16.05	15.89	12.48	8.21
	76.22	70.10	54.65	46.36	36.92	24.11
	158.78	147.02	116.28	98.64	78.55	51.29
Key metrics
	158.42	151.13	123.59	96.03	76.45	58.93
	31.88%	32.10%	31.10%	30.10%	28.50%	29.30%
	15.34%	14.90%	13.80%	14.50%	13.80%	12.00%
	—	16.10%	16.00%	—	—	—
	20.01%	18.60%	24.40%	19.20%	33.10%	—
	31.87%	28.30%	17.90%	25.60%	53.10%	—
	—	46.75	-6.88	—	—	—
	—	2.07	1.73	—	—	—
	—	0.24	0.46	—	—	—
	—	75.18	85.20	—	—	—
	—	4.6	-2.7	—	—	—
Balance sheet
	—	766.46	613.32	—	—	—
	—	136.54	55.94	—	—	—
	—	6.63	11.16	—	—	—
	—	18.71	13.97	—	—	—
	—	14.10	13.40	—	—	—
	—	4.07	1.56	—	—	—
	—	374.82	160.13	—	—	—
	—	26.84	30.20	—	—	—
	—	111.38	86.98	—	—	—
	—	81.81	96.36	—	—	—
	—	14.67	14.59	—	—	—
	—	67.14	81.77	—	—	—
	—	346.30	209.61	—	—	—
Cash flow
	—	145.14	94.48	—	—	—
	—	-173.53	-132.78	—	—	—
	—	24.78	16.58	—	—	—
	—	98.39	101.36	—	—	—

Compounded growth

Sales CAGR 3Y: +20.68%
Sales CAGR 5Y: —
Profit CAGR 3Y: +23.83%
Profit CAGR 5Y: —
Sales YoY (TTM): +20.01%
Profit YoY (TTM): +31.87%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 72.67%

Quarter	September 2026	June 2026
Promoter %	72.67%	72.67%

Holder	Type	Holding	Previous	Change
DR AGARWALS HEALTH CARE LIMITED	Promoter	72.67%	—	—
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS	Public	2.69%	2.70%	-0.01%
MALABAR INDIA FUND LIMITED	Public	2.16%	2.16%	0.00%
VARUN ASHOK HIREMATH	Public	2.06%	2.11%	-0.05%
MALABAR MIDCAP FUND	Public	1.66%	1.66%	0.00%
DR. ASHVIN AGARWAL	Promoter	0.00%	0.00%	0.00%
DR. ATHIYA AGARWAL	Promoter	0.00%	0.00%	0.00%
DR. AMAR AGARWAL	Promoter	0.00%	0.00%	0.00%
DR. ANOSH AGARWAL	Promoter	0.00%	0.00%	0.00%
DR. ADIL AGARWAL	Promoter	0.00%	0.00%	0.00%
MR. PANKAJ SONDHI	Promoter	0.00%	0.00%	0.00%
MY HAPPY PLACE PRIVATE LIMITED	Promoter Group	0.00%	0.00%	0.00%
DR. ASHAR AGARWAL	Promoter	0.00%	0.00%	0.00%
EYE RESEARCH CENTRE FOUNDATION	Promoter Group	0.00%	0.00%	0.00%
DR. SUNITA AGARWAL .	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Copy of the communication sent to equity shareholders intimating the fixation of record date is submitted.27 Oct 2026 · Company Update / General
Fixation of Record Date w.r.t. the scheme of amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is submitted.20 Oct 2026 · Corp. Action / Record Date
Outcome of Board Meeting held on October 20, 2026, in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care ....20 Oct 2026 · Others / Outcome without intimation
Disclosure under Regulation 74(5) of the SEBI (DP) Regulations, 2018, is submitted.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Receipt of sanction from the Honble NCLT, Chennai bench towards the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and its respective ....5 Oct 2026 · Company Update / Scheme of Arrangement
The disclosure on closure of trading window is submitted.28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
32nd Annual General Meeting (AGM)- Results of the remote e-voting and e-voting during the AGM along with the Scrutinizer report, is submitted.10 Sep 2026 · AGM/EGM / AGM
Summary of proceedings of the 32nd Annual General Meeting of the Company held on September 09, 2026, is submitted.9 Sep 2026 · AGM/EGM / AGM
Media Release - Launch of World''s first Pinhole Pupilloplasty (PPP) Centre by the Company, is submitted.27 Aug 2026 · Company Update / Press Release / Media Release
Newspaper Advertisement published for the 32nd Annual General Meeting is submitted.15 Aug 2026 · Company Update / Newspaper Publication
Notice convening the 32nd Annual General Meeting of the members of the Company which is scheduled to be held on September 09, 2026, is submitted.14 Aug 2026 · AGM/EGM / AGM
The record date for the payment of final dividend for the financial year 2025-26 is submitted.14 Aug 2026 · Corp. Action / Record Date
Annual Report of Dr. Agarwal's Eye Hospital Limited for the financial year 2025-26 is submitted14 Aug 2026 · Others / Reg. 34 (1) Annual Report
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Reappointment of cost auditors to conduct audit of the cost records of the Company for the financial year 2026-27, is submitted.3 Aug 2026 · Company Update / Change in Management
Unaudited Financial Results for the quarter ended June 30, 2026, is submitted.3 Aug 2026 · Result / Financial Results
Outcome of the proceedings of the Board Meeting held on August 03, 2026 is submitted.3 Aug 2026 · Board Meeting / Outcome of Board Meeting
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve the unaudited financial ....28 Jul 2026 · Board Meeting / Board Meeting
Newspaper Advertisement of the Notice of Hearing of the Company''s Petition in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health ....20 Jul 2026 · Company Update / Newspaper Publication
Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018, is submitted7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting results of the Hon''ble NCLT convened meeting of the Unsecured Creditors of Dr. Agarwal''s Eye Hospital Limited is submitted.2 Jul 2026 · Company Update / General
Summary of the proceedings of the Hon''ble NCLT convened meeting of the unsecured creditors of Dr. Agarwal''s Eye Hospital Limited is submitted.2 Jul 2026 · Company Update / General
Voting results of the Hon''ble NCLT convened meeting of the Secured Creditors of Dr. Agarwal''s Eye Hospital Limited is submitted.2 Jul 2026 · Company Update / General
Summary of the proceedings of the Honble NCLT convened meeting of the secured creditors of Dr. Agarwal''s Eye Hospital Limited held on July 02, 2026, is submitted.2 Jul 2026 · Company Update / General
The voting results of the Hon''ble NCLT convened meeting of the Equity Shareholders of Dr. Agarwal''s Eye Hospital Limited is submitted. The resolution set out in the notice have been duly ....2 Jul 2026 · AGM/EGM / Court Convened Meeting
Summary of proceedings of the NCLT convened meetings of the Equity Shareholders of Dr. Agarwal''s Eye Hospital Limited held on July 02, 2026 is submitted.2 Jul 2026 · AGM/EGM / Court Convened Meeting
Disclosure on Closure of Trading Window is submitted.20 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Re-affirmation and withdrawal of Credit Rating by CRISIL Ratings Limited with respect to the debt facilities availed by the Company is submitted.16 Jun 2026 · Company Update / Credit Rating
Joint Newspaper Advertisement of the NCLT convened meetings of the Equity Shareholders, Secured Creditors and Unsecured Creditors of the Company, is submitted.1 Jun 2026 · Company Update / Newspaper Publication
Letter providing direct weblink and a Static Quick Response Code to the Notice of the Equity Shareholders and Creditors dispatched by the Company, is submitted.1 Jun 2026 · Company Update / General
Notice convening the meeting of the unsecured creditors of the Company pursuant to the order of the Hon''ble Tribunal, Chennai Bench, is submitted.1 Jun 2026 · Company Update / Scheme of Arrangement
Notice convening the meeting of the Secured Creditors of the Company pursuant to the order of the Hon''ble NCLT, Chennai Bench.1 Jun 2026 · Company Update / Scheme of Arrangement
Notice convening the Meeting of the Equity Shareholders of the Company pursuant to the Order of Honb''le NCLT, Chennai Bench, is submitted.1 Jun 2026 · AGM/EGM / Court Convened Meeting
Declaration of Final Dividend of Rs 4/- per equity share of Rs. 10 each for the financial year ended March 31, 2026.20 May 2026 · Corp. Action / Dividend
Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Declaration of Final Dividend for the financial year ended March 31, 2026, is attached20 May 2026 · Board Meeting / Outcome of Board Meeting
Audited Financial Results of the Company for the quarter and year ended March 31, 2026, is attached.20 May 2026 · Result / Financial Results
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve The Audited Financial ....14 May 2026 · Board Meeting / Board Meeting
Receipt of Order passed by the Hon''ble NCLT, Chennai Bench, in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is attached.11 May 2026 · Company Update / General
Intimation regarding the trading and admission to dealings of the Company''s Equity Shares on the National Stock Exchange of India Limited, is attached.21 Apr 2026 · Company Update / General
Disclosure under Regulation 74(5) of SEBI (DP) Regulations is submitted.7 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 4.0000	2 Sep 2026	2 Sep 2026	—
Interim Dividend - Rs. - 3.0000	7 Nov 2025	7 Nov 2025	—
Final Dividend - Rs. - 3.5000	18 Sep 2025	18 Sep 2025	—
Interim Dividend - Rs. - 2.5000	8 Nov 2024	8 Nov 2024	—
Final Dividend - Rs. - 2.5000	19 Aug 2024	—	—

Board meetings

3 Aug 2026 Board Meeting - Financial Results